Device Trial Radar · NCT02637947
Comparison of VT Ablation Outcomes Using Remote MAGNETIC Navigation Versus Manual Approach in a Low LVEF Population
Last checked: Nov 19, 2026Latest source record: Sep 27, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
182
Actual
Start
Jan 2016
Primary completion
Feb 15, 2022
Study completion Feb 15, 2022
Sponsor
- Lead sponsor
- StereotaxisPublic (STXS)
- Sponsor type
- Industry
- First posted
- Dec 22, 2015
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study purpose is to demonstrate that ventricular tachycardia (VT) ablation using the Niobe™ ES system results in superior outcomes compared to a manual approach in subjects with ischemic scar VT in a low ejection fraction population.
Conditions
- Tachycardia, Ventricular
Interventions
catheter ablation using magnetic navigationDevice
elimination of cardiac arrhythmias through heating and destroying heart tissue with faulty electrical pathways through the use of Stereotaxis's Niobe ES System with the NaviStar RMT ThermoCool catheter or other magnetically compatible catheters.
catheter ablation using manual navigationDevice
elimination of cardiac arrhythmias through heating and destroying heart tissue with faulty electrical pathways through the use of the NaviStar ThermoCool catheter or other manually navigated catheters.
Primary outcomes
What the sponsor says the trial is designed to measure.
- freedom from any VT in the overall cohortTime frame: 12 months
Locations
16 sites in 7 countries. Site status is shown where the registry gives one.
Florida Hospital
Orlando, Florida
Augusta University
Augusta, Georgia
University of Chicago Medical Center
Chicago, Illinois
13 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.